Cormica Recognised as 2025’s Leading Pharmaceutical & Medical Device Testing Specialists
Recognition for Excellence in Regulated Testing
Cormica is proud to announce it has been awarded the title of 2025’s leading pharmaceutical and medical device testing specialists, by Global Health & Pharma Magazine (GHP).
The award recognises Cormica’s consistent delivery of high-quality, compliant testing across its global laboratory network, supporting regulated product development and release across international markets. Cormica was commended for consistent delivery of high-quality, compliant testing across our network of GMP, GLP, and ISO 17025 accredited laboratories in the UK, US, and EU. It reflects the group’s strong quality systems, deep technical expertise, and collaborative approach to supporting clients across the full product lifecycle, from early development through to regulatory submission, product release, and post-market activities.
Celebrating a Global Commitment to Quality, Compliance, and Collaboration
Cormica supports manufacturers operating in highly regulated and rapidly evolving markets, helping them navigate changing regulatory requirements and bring safe, effective products to market with confidence. Cormica’s integrated service offering spans microbiology, analytical chemistry, physical and packaging testing, biocompatibility, and regulatory support, enabling manufacturers to manage complex testing programmes through a single, coordinated partner. This joined-up approach allows clients to reduce risk, improve efficiency, and maintain confidence in product quality throughout development and commercialisation.
Central to this recognition is Cormica’s values-led culture, with a clear focus on doing what is right, taking ownership, working collaboratively across sites, and continually improving capabilities to meet evolving regulatory expectations.
By supporting manufacturers in developing, registering, and releasing medical device and pharmaceutical products, Cormica plays a vital role in enabling patient access to safe and effective therapies worldwide. The award reflects not only technical capability, but the everyday standards and decisions that underpin trust in regulated testing.
Mark Hammond
Cormica CEO
“We are proud that Cormica has been recognised as 2025’s Leading Pharmaceutical & Medical Device Testing Specialists. This award reflects the consistency, integrity, and professionalism our teams demonstrate every day across the group. Our clients rely on us for accurate, reliable, and compliant data, and this recognition reinforces the trust they place in us as their testing partner.”
Improving Patient Lives Through Trusted Testing
For our clients, the award provides independent reassurance that Cormica delivers testing services to a consistently high standard across all sites. It reinforces Cormica’s role as a dependable partner for manufacturers navigating regulatory complexity, supporting faster decision-making, smoother submissions, and confident product release across global markets.
By supporting manufacturers in developing, registering, and releasing medical device and pharmaceutical products, Cormica plays a vital role in enabling patient access to safe and effective therapies worldwide. The award reflects not only technical capability, but the everyday standards and decisions that underpin trust in regulated testing.
Laboratories near you, supporting global product success
With accredited laboratories in the UK, EU and US, we support pharmaceutical, medical device and combination product manufacturers worldwide. Local support combined with global quality, delivered by teams who understand your regulatory requirements.
Contact Us
Ready to take the next step? We’d love to hear from you. Contact us today to discuss your testing needs and find out how Cormica can help you achieve your goals.
Our Clients’ Experiences
